1.Chinese practice guideline for the prevention and treatment of mother-to-child transmission of hepatitis B virus(version 2024)
Infectious Diseases Physicians Branch,Chinese Medical Doctor Association ; Chinese Society of Infectious Diseases,Chinese Medical Association ; Yingren ZHAO ; Lanjuan LI ; Wenhong ZHANG
Journal of Clinical Hepatology 2024;40(8):1557-1566
The 2019 Chinese practice guideline for the prevention and treatment of mother-to-child transmission of hepatitis B virus developed by Chinese Society of Infectious Diseases,Chinese Medical Association,has shown a good guiding effect in standardizing the process for blocking the mother-to-child transmission of hepatitis B virus in China.Clinical practice guidelines and consensus statements require timely updates based on new research evidence,in order to better guide clinical practice and research.Chinese Physician Association for Infectious Diseases,Chinese Medical Doctor Association,and Chinese Society of Infectious Diseases,Chinese Medical Association,cooperated with multidisciplinary experts and performed updates and supplementations to the above guideline,in order to provide guidance and a reference for clinical physicians and medical staff engaged in maternal and child health care.
2. Expert consensus guidelines on clinical use of Xiyanping injection for acute infectious diseases
Banghan DING ; Bangjiang FANG ; Jun LI ; Qingquan LIU ; Chuanzhu LV ; Xuezhong YU ; Xiaodong ZHAO ; Banghan DING ; Bangjiang FANG ; Jun LI ; Qingquan LIU ; Chuanzhu LV ; Xuezhong YU ; Xiaodong ZHAO ; Banghan DING ; Bangjiang FANG ; Jun LI ; Qingquan LIU ; Chuanzhu LV ; Xuezhong YU ; Xiaodong ZHAO ; Banghan DING ; Bangjiang FANG ; Jun LI ; Qingquan LIU ; Chuanzhu LV ; Xuezhong YU ; Xiaodong ZHAO ; Banghan DING ; Bangjiang FANG ; Jun LI ; Qingquan LIU ; Chuanzhu LV ; Xuezhong YU ; Xiaodong ZHAO ; Banghan DING ; Bangjiang FANG ; Jun LI ; Qingquan LIU ; Chuanzhu LV ; Xuezhong YU ; Xiaodong ZHAO ; Banghan DING ; Bangjiang FANG ; Jun LI ; Qingquan LIU ; Chuanzhu LV ; Xuezhong YU ; Xiaodong ZHAO
Asian Pacific Journal of Tropical Medicine 2020;13(4):152-161
Xiyanping injection, a traditional Chinese medicine injection made of andrographolide sulfonate, consisting of well-defined ingredients with antiviral, antibacterial, anti-inflammatory and antipyretic efficacy, has been widely used for treating infectious diseases of respiratory and digestive systems. However, its wide applications may easily lead to unreasonable clinical medication. In order to guide the precise clinical application and rational use of Xiyanping injection, experts in related fields conducted systematically literature review, evaluated and deliberated the application of Xiyanping injection in treating acute infectious diseases using evidence-based medicine method, and jointly drafted the consensus to summarize types of acute infectious diseases in children and adults that can be treated with Xiyanping injection, and recommend the intervention time, usage and dosage, course of treatment and combined medication of the injection. Besides, the consensus elucidates the safety, precautions and contraindications of the injection, so as to provide guidance for clinical use.